English

Hinge Health, Inc.

EDGAR

HNGE Quarterly report (10-Q) · filed 2026-08-06

Annual consolidated revenue for 2025: about USD 587.9M, using the latest reported figures. The previous period, 2024, was about USD 390.4M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

213 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 212817000 USD Source

Operating margin

19%

2026 Q2 · %

Exact inputs and evidence

Operating Income: 40440000 USD Source
Revenue: 212817000 USD Source

Operating cash flow

101 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 144496000 USD Source
Operating Cash Flow: 43083000 USD Source

Free cash flow

101 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 144496000 USD Source
Operating Cash Flow: 43083000 USD Source
Capital Expenditure: 206000 USD Source
Capital Expenditure: 83000 USD Source

Cash and cash equivalents: 286 million USD 2026-06-30 Source
Exact value

286224000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 0 shares 2025-12-31 Source
Exact value

0 shares

Reported share-count change

-100.00% · -16.4 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

16379906 shares · 2024-12-31· Source
0 shares · 2025-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

720 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 154211000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 587860000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 417134000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 182307000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 212817000 USD · 2026-04-01 – 2026-06-30 Source

Net income

109 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -1844000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -528261000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -560356000 USD · 2025-01-01 – 2025-09-30 Source
Net income: 35128000 USD · 2026-01-01 – 2026-03-31 Source
Net income: 43690000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

291 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: 107548000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 25150000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: 171441000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: 107548000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 43083000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: 144496000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: 43083000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

666 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 300000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 248000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 708000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 300000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 83000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 206000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 83000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

290 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: 107548000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 25150000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: 171441000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: 107548000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 43083000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: 144496000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: 43083000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 300000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 248000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 708000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 300000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 83000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 206000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 83000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-06.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2025-12-31
Operating income: 3 of 11 periods available· newest 2025-12-31
Net income: 3 of 11 periods available· newest 2025-12-31
Operating cash flow: 3 of 11 periods available· newest 2025-12-31
Capital expenditure: 3 of 11 periods available· newest 2025-12-31
Total assets: 2 of 11 periods available· newest 2025-12-31
Total liabilities: 2 of 11 periods available· newest 2025-12-31
Current assets: 2 of 11 periods available· newest 2025-12-31
Current liabilities: 2 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+50.6%

Prior period

USD 390.4 million

2024-01-01 – 2024-12-31
Current period

USD 587.86 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

587860000 − 390404000 = 197456000 USD

390404000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
587860000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Hinge Health, Inc. · 2025-12-31 Hinge Health, Inc. (edgar:1673743) Year-over-year change in Revenue: 197456000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 587860000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1158110 Filing: 000162828026013808 Input fundies:Revenue: 390404000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1158993 Filing: 000162828026013808
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 516.33 million

Prior period

−USD 11.93 million

2024-01-01 – 2024-12-31
Current period

−USD 528.26 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-528261000 − -11933000 = -516328000 USD

-11933000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-528261000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Hinge Health, Inc. · 2025-12-31 Hinge Health, Inc. (edgar:1673743) Year-over-year change in Net income: -516328000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -528261000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#2113695 Filing: 000162828026013808 Input fundies:NetIncome: -11933000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#2114470 Filing: 000162828026013808
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+249.9%

Prior period

USD 49 million

2024-01-01 – 2024-12-31
Current period

USD 171.44 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

171441000 − 49002000 = 122439000 USD

49002000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
171441000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Hinge Health, Inc. · 2025-12-31 Hinge Health, Inc. (edgar:1673743) Year-over-year change in Operating cash flow: 122439000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 171441000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1363815 Filing: 000162828026013808 Input fundies:OperatingCashFlow: 49002000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1364462 Filing: 000162828026013808
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-31.9%

Prior period

USD 1.04 million

2024-01-01 – 2024-12-31
Current period

USD 708,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

708000 − 1039000 = -331000 USD

1039000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
708000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Hinge Health, Inc. · 2025-12-31 Hinge Health, Inc. (edgar:1673743) Year-over-year change in Capital expenditure: -331000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 708000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1366597 Filing: 000162828026013808 Input fundies:CapitalExpenditure: 1039000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1367155 Filing: 000162828026013808
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 587.86 million 100% of revenue
Cost of revenue USD 119.64 million 20% of revenue
Operating expenses USD 1.01 billion 173% of revenue
Operating income −USD 546.37 million −93% of revenue
Tax, interest and other Derived −USD 18.11 million −3.1% of revenue
Net income −USD 528.26 million −90% of revenue

Cash

Operating cash flow USD 171.44 million 29% of revenue
Capital expenditure USD 708,000 0.1% of revenue
Free cash flow Derived USD 170.73 million 29% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2023 Operating loss: operating costs were 145% of revenue.
2024 Operating loss: operating costs were 108% of revenue.
2025 Operating loss: operating costs were 193% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2023 2023-01-01 – 2023-12-31	292730000	423244000 Derived	-130514000	-22373000 Derived	-108141000	-65885000 Derived	Source 2023-01-01 – 2023-12-31: 292730000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -130514000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -108141000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -63909000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 1976000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	390404000	422314000 Derived	-31910000	-19977000 Derived	-11933000	47963000 Derived	Source 2024-01-01 – 2024-12-31: 390404000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -31910000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -11933000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 49002000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 1039000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	587860000	1134231000 Derived	-546371000	-18110000 Derived	-528261000	170733000 Derived	Source 2025-01-01 – 2025-12-31: 587860000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -546371000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -528261000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: 171441000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 708000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 587.9M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20232023-12-31	Revenue	292730000	Revenue: 292730000 Open source
20242024-12-31	Revenue	390404000	Revenue: 390404000 Open source
20252025-12-31	Revenue	587860000	Revenue: 587860000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

50.6% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20232023-12-31	Year over year	No prior comparable period	Revenue: 292730000 Open source
20242024-12-31	Year over year	33.4%	Revenue: 390404000 Open source Revenue: 292730000 Open source
20252025-12-31	Year over year	50.6%	Revenue: 587860000 Open source Revenue: 390404000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -92.9% 2025

Net margin -89.9% 2025

Free cash flow margin 29% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20232023-12-31	Operating margin	-44.6%	Operating Income: -130514000 Open source Revenue: 292730000 Open source
20242024-12-31	Operating margin	-8.2%	Operating Income: -31910000 Open source Revenue: 390404000 Open source
20252025-12-31	Operating margin	-92.9%	Operating Income: -546371000 Open source Revenue: 587860000 Open source
20232023-12-31	Net margin	-36.9%	Net Income: -108141000 Open source Revenue: 292730000 Open source
20242024-12-31	Net margin	-3.1%	Net Income: -11933000 Open source Revenue: 390404000 Open source
20252025-12-31	Net margin	-89.9%	Net Income: -528261000 Open source Revenue: 587860000 Open source
20232023-12-31	Free cash flow margin	-22.5%	Revenue: 292730000 Open source Operating Cash Flow: -63909000 Open source Capital Expenditure: 1976000 Open source
20242024-12-31	Free cash flow margin	12.3%	Revenue: 390404000 Open source Operating Cash Flow: 49002000 Open source Capital Expenditure: 1039000 Open source
20252025-12-31	Free cash flow margin	29%	Revenue: 587860000 Open source Operating Cash Flow: 171441000 Open source Capital Expenditure: 708000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 171.4M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20232023-12-31	Operating cash flow	-63909000	Operating Cash Flow: -63909000 Open source
20242024-12-31	Operating cash flow	49002000	Operating Cash Flow: 49002000 Open source
20252025-12-31	Operating cash flow	171441000	Operating Cash Flow: 171441000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 170.7M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20232023-12-31	Free cash flow	-65885000	Operating Cash Flow: -63909000 Open source Capital Expenditure: 1976000 Open source
20242024-12-31	Free cash flow	47963000	Operating Cash Flow: 49002000 Open source Capital Expenditure: 1039000 Open source
20252025-12-31	Free cash flow	170733000	Operating Cash Flow: 171441000 Open source Capital Expenditure: 708000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

49.2% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2023-12-31	Liabilities / assets	Not reported	No source recorded
20242024-12-31	Liabilities / assets	38.1%	Total Liabilities: 256557000 Open source Total Assets: 673259000 Open source
20252025-12-31	Liabilities / assets	49.2%	Total Liabilities: 366225000 Open source Total Assets: 744761000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.47× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2023-12-31	Current assets / current liabilities	Not reported	No source recorded
20242024-12-31	Current assets / current liabilities	2.34×	Current Assets: 583446000 Open source Current Liabilities: 249299000 Open source
20252025-12-31	Current assets / current liabilities	1.47×	Current Assets: 533904000 Open source Current Liabilities: 362409000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2023 2023-01-01 – 2023-12-31	−USD 108.14 million Exact value Exact value: -108141000 USD 2023-01-01 – 2023-12-31: -108141000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Hinge Health, Inc. · 2023-12-31 Hinge Health, Inc. (edgar:1673743) Net Income: -108141000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -108141000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#2115245 Filing: 000162828026013808 The citation records this snapshot. The page link may show a newer release later.	−USD 63.91 million Exact value Exact value: -63909000 USD 2023-01-01 – 2023-12-31: -63909000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Hinge Health, Inc. · 2023-12-31 Hinge Health, Inc. (edgar:1673743) Operating Cash Flow: -63909000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -63909000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1365110 Filing: 000162828026013808 The citation records this snapshot. The page link may show a newer release later.	USD 1.98 million Exact value Exact value: 1976000 USD 2023-01-01 – 2023-12-31: 1976000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Hinge Health, Inc. · 2023-12-31 Hinge Health, Inc. (edgar:1673743) Capital Expenditure: 1976000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1976000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1367745 Filing: 000162828026013808 The citation records this snapshot. The page link may show a newer release later.	−USD 65.89 million Calculation and evidence -63909000 − 1976000 USD Exact free cash flow: -65885000 USD 2023-01-01 – 2023-12-31: -63909000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 1976000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Hinge Health, Inc. · 2023-12-31 Hinge Health, Inc. (edgar:1673743) Free cash flow: -65885000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -63909000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1365110 Filing: 000162828026013808 Input fundies:CapitalExpenditure: 1976000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1367745 Filing: 000162828026013808 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 11.93 million Exact value Exact value: -11933000 USD 2024-01-01 – 2024-12-31: -11933000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Hinge Health, Inc. · 2024-12-31 Hinge Health, Inc. (edgar:1673743) Net Income: -11933000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11933000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#2114470 Filing: 000162828026013808 The citation records this snapshot. The page link may show a newer release later.	USD 49 million Exact value Exact value: 49002000 USD 2024-01-01 – 2024-12-31: 49002000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Hinge Health, Inc. · 2024-12-31 Hinge Health, Inc. (edgar:1673743) Operating Cash Flow: 49002000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 49002000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1364462 Filing: 000162828026013808 The citation records this snapshot. The page link may show a newer release later.	USD 1.04 million Exact value Exact value: 1039000 USD 2024-01-01 – 2024-12-31: 1039000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Hinge Health, Inc. · 2024-12-31 Hinge Health, Inc. (edgar:1673743) Capital Expenditure: 1039000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1039000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1367155 Filing: 000162828026013808 The citation records this snapshot. The page link may show a newer release later.	USD 47.96 million Calculation and evidence 49002000 − 1039000 USD Exact free cash flow: 47963000 USD 2024-01-01 – 2024-12-31: 49002000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 1039000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Hinge Health, Inc. · 2024-12-31 Hinge Health, Inc. (edgar:1673743) Free cash flow: 47963000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 49002000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1364462 Filing: 000162828026013808 Input fundies:CapitalExpenditure: 1039000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1367155 Filing: 000162828026013808 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 528.26 million Exact value Exact value: -528261000 USD 2025-01-01 – 2025-12-31: -528261000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Hinge Health, Inc. · 2025-12-31 Hinge Health, Inc. (edgar:1673743) Net Income: -528261000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -528261000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#2113695 Filing: 000162828026013808 The citation records this snapshot. The page link may show a newer release later.	USD 171.44 million Exact value Exact value: 171441000 USD 2025-01-01 – 2025-12-31: 171441000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Hinge Health, Inc. · 2025-12-31 Hinge Health, Inc. (edgar:1673743) Operating Cash Flow: 171441000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 171441000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1363815 Filing: 000162828026013808 The citation records this snapshot. The page link may show a newer release later.	USD 708,000 Exact value Exact value: 708000 USD 2025-01-01 – 2025-12-31: 708000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Hinge Health, Inc. · 2025-12-31 Hinge Health, Inc. (edgar:1673743) Capital Expenditure: 708000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 708000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1366597 Filing: 000162828026013808 The citation records this snapshot. The page link may show a newer release later.	USD 170.73 million Calculation and evidence 171441000 − 708000 USD Exact free cash flow: 170733000 USD 2025-01-01 – 2025-12-31: 171441000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 708000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Hinge Health, Inc. · 2025-12-31 Hinge Health, Inc. (edgar:1673743) Free cash flow: 170733000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1673743?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 171441000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1363815 Filing: 000162828026013808 Input fundies:CapitalExpenditure: 708000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm#1366597 Filing: 000162828026013808 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

8 filings · 718 latest values · 718 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001673743, 1673743, HNGE, edgar:1673743

Also known as Hinge Health, Inc.

Hinge Health, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation